Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -248,226 | -381,641 | -64,772 | -41,839 |
| Depreciation Amortization | -17,990 | -10,380 | -246 | N/A |
| Accounts payable and accrued liabilities | -37,032 | 34,443 | 3,776 | 1,119 |
| Other Working Capital | -77,352 | 52,079 | -67 | 11,627 |
| Other Operating Activity | 76,679 | 135,794 | -211 | 24,114 |
| Operating Cash Flow | $-303,921 | $-169,705 | $-61,520 | $-4,979 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 139,096 | -583,153 | -47,791 | N/A |
| PPE Investments | 5,753 | -12,294 | N/A | -25,000 |
| Net Acquisitions | N/A | 10,007 | -83 | N/A |
| Sale Of Investment | 10,016 | 137,696 | N/A | N/A |
| Investing Cash Flow | $154,865 | $-447,744 | $-47,874 | $-25,000 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 7,330 | 2,627 | N/A | 16 |
| Other Financing Activity | -1,937 | 565,809 | 274,262 | 124,704 |
| Financing Cash Flow | $5,393 | $568,436 | $274,262 | $124,720 |
| Beginning Cash Position | 218,097 | 267,110 | 102,242 | 7,501 |
| End Cash Position | 74,434 | 218,097 | 267,110 | 102,242 |
| Net Cash Flow | $-143,663 | $-49,013 | $164,868 | $94,741 |
| Free Cash Flow | ||||
| Operating Cash Flow | -303,921 | -169,705 | -61,520 | -4,979 |
| Capital Expenditure | -1,247 | -12,294 | N/A | -25,000 |
| Free Cash Flow | -305,168 | -181,999 | -61,520 | -29,979 |